Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Temporal GCA needs immediate attention
Anaheim, CA-Temporal giant cell arteritis (GCA) is potentially devastating if not recognized and treated early. Even early intervention may not reverse or prevent visual loss. Neil R. Miller, MD, provided his approach to recognizing and managing this systemic disease of the elderly during the annual meeting of the American Academy of Ophthalmology.
Related Videos
Related Content
